 |
|
| ADVANCES IN CANCER RESEARCH, 88
| |
| | |
|
|
To order this title, and for more information, click here
By
George Vande Woude, Director, Van Andel Research Institute, Grand Rapids, MI, USA
Included in series
Advances in Cancer Research,
Description
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer
research. This volume presents outstanding and original reviews on a variety of topics, including HAMLET and tumor cells; survivin and
apoptosis control; retroviral insertional mutagenesis; aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and
oncogenesis; and epigenetic variability and the evolution of human cancer.
Audience
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology.
Contents
HAMLET Kills Tumor Cells by Apoptosis - Cellular, Molecular and Therapeutic Aspects; Survivin and Apoptosis Control; Retroviral Insertional
Mutagenesis: Tagging Cancer Pathways; Aberrant Ubiquitin-Mediated Proteolysis of Cell Cycle Regulatory Proteins and Oncogenesis; Epigenetic
Variability and the Evolution of Human Cancer
| Bibliographic details |
Hardbound, 173 pages, publication date: MAR-2003
ISBN-13: 978-0-12-006688-9
ISBN-10: 0-12-006688-2
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
USD 150
EUR 106.95
GBP 90.99
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/925
Last update: 3 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company